PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma
| Image |  |
|---|---|
| Description | scientific article published on 14 November 2019 |
| Author/s |
author: Naveen S Vasudev Kate Fife |
| Publication date | November 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |